1:00

Testing the reliability of the causal relationship: Considering genetic and environmental susceptibility

Mikhail Pletnikov, Johns Hopkins University School of Medicine

1:30

DNA sequence analysis of a stealth-adapted simian cytomegalovirus

W. John Martin, Center for Complex Infectious Diseases

2:00

Development of vaccines to prevent chronic disease

P. Helena Mäkelä, National Public Health Institute, Helsinki, Finland

2:30

Integrating epidemiology, laboratory research, and surveillance

Siobhán O’Connor, Centers for Disease Control and Prevention

3:00

BREAK

Session VI Discussion Panel: The Next Steps for the Healthcare Community

Panel members, Forum members, and the audience will comment on and respond to considerations such as the role of industry and academic research in developing treatments; the implications for the health care and prevention community in detecting and treating these diseases; and the benefits of managing acute infections vs. chronic diseases—the argument for vaccines and antimicrobials.

3:15

Kathryn Carbone, FDA, Center for Biologics Evaluation and Research

Thomas Shinnick, Centers for Disease Control and Prevention

5:00

Closing Remarks / Adjournment



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement